Warfarin dosing by genotype did not improve time in therapeutic range

被引：0
|
作者：
Dunn, Andrew [1 ]
机构：
[1] Mt Sinai Hlth Syst, New York, NY 10029 USA
来源：
ANNALS OF INTERNAL MEDICINE | 2014年 / 160卷 / 06期
关键词：
PHARMACOGENETICS; POLYMORPHISMS; INITIATION; CYP2C9; TRIAL;
D O I：
10.7326/0003-4819-160-6-201403180-02008
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] In AF or VTE, warfarin dosing by genotype improved time in therapeutic range but not clinical outcomes
    Pirmohamed, M.
    Burnside, G.
    Eriksson, N.
    ANNALS OF INTERNAL MEDICINE, 2014, 160 (06)
  • [2] In AF or VTE, acenocoumarol or phenprocoumon dosing by genotype did not affect time in therapeutic range
    Dunn, Andrew
    ANNALS OF INTERNAL MEDICINE, 2014, 160 (06)
  • [3] GENOTYPE GUIDED THERAPEUTIC DOSING OF WARFARIN IN GERIATRIC PATIENTS
    Radhakrishnan, Anita
    Vido, Diane
    Tayur, Sridhar
    Akan, Mustafa
    Murali, Srinivas
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (13) : E1696 - E1696
  • [4] Pharmacogenetics of warfarin in a paediatric population: time in therapeutic range, initial and stable dosing and adverse effects
    Hawcutt, D. B.
    Ghani, A. A.
    Sutton, L.
    Jorgensen, A.
    Zhang, E.
    Murray, M.
    Michael, H.
    Peart, I.
    Smyth, R. L.
    Pirmohamed, M.
    PHARMACOGENOMICS JOURNAL, 2014, 14 (06): : 542 - 548
  • [5] Pharmacogenetics of warfarin in a paediatric population: time in therapeutic range, initial and stable dosing and adverse effects
    D B Hawcutt
    A A Ghani
    L Sutton
    A Jorgensen
    E Zhang
    M Murray
    H Michael
    I Peart
    R L Smyth
    M Pirmohamed
    The Pharmacogenomics Journal, 2014, 14 : 542 - 548
  • [6] Genotype-Guided Vitamin K Antagonist Dosing Algorithms Improve Time in Therapeutic Range: A Systematic Review and Meta-Analysis
    BeIley-Cote, Emilie P.
    Hanif, Hasib
    D'Aragon, Frederick
    Eikelboom, John
    Anderson, Jeffrey L.
    Borgman, Mark
    Jonas, Daniel E.
    Kimmel, Stephen
    Maitland-van der Zee, Anke H.
    Pirmohamed, Munir
    Whitlock, Richard
    CIRCULATION, 2014, 130
  • [7] Genotype-Guided Dosing of Warfarin
    Mega, Jessica L.
    Giugliano, Robert P.
    CLINICAL CHEMISTRY, 2014, 60 (07) : 920 - 922
  • [8] Genotype-guided warfarin dosing
    Laffman-Johnson, Elise
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 95 (03) : 236 - 236
  • [9] Impact of Initial Warfarin Dosing on Time in Therapeutic Range for Postoperative Left Ventricular Assist Device Patients
    Olson, Logan M.
    Korkames, Grace C.
    Lyden, Elizabeth R.
    Ryan, Timothy R.
    Bowman, Stephanie A.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2022, 80 (03) : 471 - 475
  • [10] Time in therapeutic range values of patients using warfarin and factors that influence time in therapeutic range
    Asarcikli, Lale Dinc
    Kafes, Habibe
    Sen, Taner
    Ipek, Esra Gucuk
    Cebeci, Muhammet
    Gul, Murat
    Kanat, Selcuk
    Temizhan, Ahmet
    TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, 2021, 49 (06): : 463 - 473
12345